Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - OPERATING EXPENSES
Operating Expenses APLS - Apellis Pharmaceuticals, Inc.
855 M
LAST VALUE
19.62%
2 YEAR CAGR
46.23%
5 YEAR CAGR
70.88%
10 YEAR CAGR